Dr. S Vincent Rajkumar discusses risk stratification of plasma cell disorders during the Friday Satellite Symposium preceding the 60th ASH Annual Meeting & Exposition.
This video is the first in a five-part series that focuses on new strategies for multiple myeloma care. It was presented during the Friday Satellite Symposium preceding the 60th ASH Annual Meeting & Exposition in San Diego, CA.
Other topics include:
- Risk stratification of plasma cell disorders
- Are we ready for personalized therapy in newly diagnosed MM?
- Considering the recent data on transplantation, consolidation, and maintenance after induction therapy
- Advances in the optimal choice of therapeutic strategies for patients with relapsed/refractory disease
- Proposed 2019 treatment algorithms for MM
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower, International Myeloma Foundation, and Clinical Care Options, LLC
This activity is supported by educational grants from AbbVie; Amgen; Bristol-Myers Squibb; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.
**Due to technical problems during recording parts of the video may have no audio**
Please subscribe to our channel!
Subscribe to International Myeloma Foundation: [ Ссылка ]
Visit our website at: [ Ссылка ]
Find us online:
Facebook: [ Ссылка ]
Google+: [ Ссылка ]
IMF on twitter: @IMFMyeloma ([ Ссылка ])
Dr. Durie on twitter: @BrianDurieMD ([ Ссылка ])
Support the IMF! [ Ссылка ]
Category
Nonprofits & Activism
License
Standard YouTube License
![](https://i.ytimg.com/vi/HLClasPV0BQ/maxresdefault.jpg)